A Machine Learning Approach to Identify Patients With Resected Non-small-cell Lung Cancer With High Risk of Relapse
Condition(s):Non-small Cell Lung Cancer Stage IIIALast Updated:September 21, 2023Recruiting
Include Studies Not Open or Pending
Condition(s):Non-small Cell Lung Cancer Stage IIIALast Updated:September 21, 2023Recruiting
Condition(s):Non-Small Cell Lung CancerLast Updated:January 27, 2022Recruiting
Condition(s):Non-Small Cell Lung CancerLast Updated:March 21, 2023Not yet recruiting
Condition(s):Carcinoma, Non-Small-Cell LungLast Updated:March 12, 2024Recruiting
Condition(s):Carcinoma, Non-Small-Cell LungLast Updated:September 15, 2023Recruiting
Condition(s):Non-small Cell Lung CancerLast Updated:February 9, 2024Recruiting
Condition(s):Lung Cancer Non-small Cell Stage IVLast Updated:March 8, 2023Recruiting
Condition(s):Advanced Non-small Cell Lung CancerLast Updated:September 11, 2023Recruiting
Condition(s):Carcinoma, Non-Small-Cell LungLast Updated:December 8, 2023Recruiting
Condition(s):Carcinoma, Non-Small-Cell LungLast Updated:March 13, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.